Table of Contents
ISRN AIDS
Volume 2012 (2012), Article ID 145127, 14 pages
http://dx.doi.org/10.5402/2012/145127
Clinical Study

Moderate-Intensity Exercise Improves Body Composition and Improves Physiological Markers of Stress in HIV-Infected Men

1Department of Health, Exercise, and Sport Science, The Citadel, 171 Moultrie Street, Charleston, SC 29403, USA
2Department of Exercise Science, Arnold School of Public Health, University of South Carolina, 1300 Wheat Street, Columbia, SC 29208, USA
3College of Nursing, University of Tennessee, 4520 Ivy Rose Drive, Knoxville, TN 37918, USA
4College of Nursing, University of South Carolina, 1601 Greene Street, Columbia, SC 29208, USA
5Department of Health, Kinesiology, and Sports Studies, Coastal Carolina University, P.O. Box 261954, Conway, SC 29528-6054, USA

Received 18 October 2012; Accepted 11 November 2012

Academic Editors: D. Aunis, R. L. D. Machado, and J. Poudrier

Copyright © 2012 Wesley David Dudgeon et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. UNIADS, “UNAIDS global report on the AIDS epidemic,” Tech. Rep., 2010. View at Google Scholar
  2. R. P. Walensky, A. D. Paltiel, E. Losina et al., “The survival benefits of AIDS treatment in the United States,” Journal of Infectious Diseases, vol. 194, no. 1, pp. 11–19, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Zwahlen, R. Harris, M. May, R. Hogg, D. Costagliola, F. de Wolf et al., “Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries,” International Journal of Epidemiology, vol. 38, no. 6, Article ID dyp306, pp. 1624–1633, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. F. J. Palella Jr., K. M. Delaney, A. C. Moorman et al., “Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection,” New England Journal of Medicine, vol. 338, no. 13, pp. 853–860, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. R. S. Braithwaite, A. C. Justice, C. C. H. Chang et al., “Estimating the proportion of patients infected with HIV who will die of comorbid diseases,” American Journal of Medicine, vol. 118, no. 8, pp. 890–898, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Grinspoon and A. Carr, “Cardiovascular risk and body-fat abnormalities in HIV-infected adults,” New England Journal of Medicine, vol. 352, no. 1, pp. 48–62, 2005. View at Publisher · View at Google Scholar · View at Scopus
  7. C. A. Wanke, M. Silva, T. A. Knox, J. Forrester, D. Speigelman, and S. L. Gorbach, “Weight loss and wasting remain common complications in individuals infected with human immunodeficiency virus in the era of highly active antiretroviral therapy,” Clinical Infectious Diseases, vol. 31, no. 3, pp. 803–805, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. A. J. S. Coats, “Origin of symptoms in patients with cachexia with special reference to weakness and shortness of breath,” International Journal of Cardiology, vol. 85, no. 1, pp. 133–139, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Schwenk, A. Beisenherz, K. Romer, G. Kremer, B. Salzberger, and M. Elia, “Phase angle from bioelectrical impedance analysis remains an independent predictive marker in HIV-infected patients in the era of highly active antiretroviral treatment,” American Journal of Clinical Nutrition, vol. 72, no. 2, pp. 496–501, 2000. View at Google Scholar · View at Scopus
  10. S. Grinspoon, C. Corcoran, D. Rosenthal et al., “Quantitative assessment of cross-sectional muscle area, functional status, and muscle strength in men with the acquired immunodeficiency syndrome wasting syndrome,” Journal of Clinical Endocrinology and Metabolism, vol. 84, no. 1, pp. 201–206, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Guenter, N. Muurahainen, G. Simons et al., “Relationships among nutritional status, disease progression, and survival in HIV infection,” Journal of Acquired Immune Deficiency Syndromes, vol. 6, no. 10, pp. 1130–1138, 1993. View at Google Scholar · View at Scopus
  12. M. C. Gelato and R. A. Frost, “IGFBP-3: functional and structural implications in aging and wasting syndromes,” Endocrine, vol. 7, no. 1, pp. 81–85, 1997. View at Google Scholar · View at Scopus
  13. M. S. Dworkin and J. M. Williamson, “AIDS wasting syndrome: trends, influence on opportunistic infections, and survival,” Journal of Acquired Immune Deficiency Syndromes, vol. 33, no. 2, pp. 267–273, 2003. View at Google Scholar · View at Scopus
  14. D. P. Kotler, A. R. Tierney, J. Wang, and R. N. Pierson, “Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS,” American Journal of Clinical Nutrition, vol. 50, no. 3, pp. 444–447, 1989. View at Google Scholar · View at Scopus
  15. A. Biglino, P. Limone, B. Forno et al., “Altered adrenocorticotropin and cortisol response to corticotropin-releasing hormone in HIV-1 infection,” European Journal of Endocrinology, vol. 133, no. 2, pp. 173–179, 1995. View at Google Scholar · View at Scopus
  16. N. Christeff, S. Gharakhanian, N. Thobie, W. Rozenbaum, and E. A. Nunez, “Evidence for changes in adrenal and testicular steroids during HIV infection,” Journal of Acquired Immune Deficiency Syndromes, vol. 5, no. 8, pp. 841–846, 1992. View at Google Scholar · View at Scopus
  17. J. M. Villette, P. Bourin, C. Doinel et al., “Circadian variations in plasma levels of hypophyseal, adrenocortical and testicular hormones in men infected with human immunodeficiency virus,” Journal of Clinical Endocrinology and Metabolism, vol. 70, no. 3, pp. 572–577, 1990. View at Google Scholar · View at Scopus
  18. R. Breitkreutz, J. Wagner, M. Tokus et al., “Flux of amino acids and energy substrates across the leg in weight-stable HIV-infected patients with acute opportunistic infections: indication of a slow protein wasting process,” Journal of Molecular Medicine, vol. 79, no. 11, pp. 671–678, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Lehrke, U. C. Broedl, I. M. Biller-Friedmann et al., “Serum concentrations of cortisol, interleukin 6, leptin and adiponectin predict stress induced insulin resistance in acute inflammatory reactions,” Critical Care, vol. 12, no. 6, article no. R157, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Hameed, R. W. Orrell, M. Cubbold, G. Goldspink, and S. D. R. Harridge, “Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise,” Journal of Physiology, vol. 547, no. 1, pp. 247–254, 2003. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Grinspoon, C. Corcoran, K. Lee et al., “Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting,” Journal of Clinical Endocrinology and Metabolism, vol. 81, no. 11, pp. 4051–4058, 1996. View at Publisher · View at Google Scholar · View at Scopus
  22. M. C. Gelato and R. A. Frost, “IGFBP-3: functional and structural implications in aging and wasting Syndromes,” Endocrine, vol. 7, no. 1, pp. 81–85, 1997. View at Google Scholar · View at Scopus
  23. A. S. Dobs, “Androgen therapy in AIDS wasting,” Bailliere's Clinical Endocrinology and Metabolism, vol. 12, no. 3, pp. 379–390, 1998. View at Google Scholar · View at Scopus
  24. R. C. Griggs, D. Halliday, W. Kingston, and R. T. Moxley, “Effect of testosterone on muscle protein synthesis in myotonic dystrophy,” Annals of Neurology, vol. 20, no. 5, pp. 590–596, 1986. View at Google Scholar · View at Scopus
  25. R. J. Urban, Y. H. Bodenburg, C. Gilkison et al., “Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis,” American Journal of Physiology, vol. 269, no. 5, part 1, pp. E820–E826, 1995. View at Google Scholar · View at Scopus
  26. F. C. W. Wu, “Endocrine aspects of anabolic steroids,” Clinical Chemistry, vol. 43, no. 7, pp. 1289–1292, 1997. View at Google Scholar · View at Scopus
  27. T. A. Robertson, M. A. L. Maley, M. D. Grounds, and J. M. Papadimitriou, “The role of macrophages in skeletal muscle regeneration with particular reference to chemotaxis,” Experimental Cell Research, vol. 207, no. 2, pp. 321–331, 1993. View at Publisher · View at Google Scholar · View at Scopus
  28. R. Schindler, J. Mancilla, S. Endres, R. Ghorbani, S. C. Clark, and C. A. Dinarello, “Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF,” Blood, vol. 75, no. 1, pp. 40–47, 1990. View at Google Scholar · View at Scopus
  29. S. D. Anker and M. Rauchhaus, “Insights into the pathogenesis of chronic heart failure: immune activation and cachexia,” Current Opinion in Cardiology, vol. 14, no. 3, pp. 211–216, 1999. View at Publisher · View at Google Scholar · View at Scopus
  30. M. O. Farber and E. T. Mannix, “Tissue wasting in patients with chronic obstructive pulmonary disease, the acquired immune deficiency syndrome, and congestive heart failure,” Neurologic Clinics, vol. 18, no. 1, pp. 245–262, 2000. View at Google Scholar · View at Scopus
  31. M. J. Tisdale, “Wasting in cancer,” Journal of Nutrition, vol. 129, no. 1, supplement, pp. 243S–246S, 1999. View at Google Scholar
  32. L. L. Moldawer and F. R. Sattler, “Human immunodeficiency virus-associated wasting and mechanisms of cachexia associated with inflammation,” Seminars in Oncology, vol. 25, no. 1, supplement 1, pp. 73–81, 1998. View at Google Scholar · View at Scopus
  33. D. R. Luke, B. J. McCreedy, T. P. Sarnoski et al., “Phase I/II study of pentoxifylline with zidovudine on HIV-1 growth in AIDS patients,” International Journal of Clinical Pharmacology Therapy and Toxicology, vol. 31, no. 7, pp. 343–350, 1993. View at Google Scholar · View at Scopus
  34. N. Wig, P. Anupama, S. Singh et al., “Tumor necrosis factor-α levels in patients with HIV with wasting in South Asia,” AIDS Patient Care and STDs, vol. 19, no. 4, pp. 212–215, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. P. T. Larsson, S. Hallerstam, S. Rosfors, and N. H. Wallén, “Circulating markers of inflammation are related to carotid artery atherosclerosis,” International Angiology, vol. 24, no. 1, pp. 43–51, 2005. View at Google Scholar · View at Scopus
  36. P. M. Ridker, J. E. Buring, N. R. Cook, and N. Rifai, “C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women,” Circulation, vol. 107, no. 3, pp. 391–397, 2003. View at Google Scholar · View at Scopus
  37. J. H. Schwab, S. K. Anderle, R. R. Brown, F. G. Dalldorf, and R. C. Thompson, “Pro- and anti-inflammatory roles of interleukin-1 in recurrence of bacterial cell wall-induced arthritis in rats,” Infection and Immunity, vol. 59, no. 12, pp. 4436–4442, 1991. View at Google Scholar · View at Scopus
  38. G. Ku, C. E. Thomas, A. L. Akeson, and R. L. Jackson, “Induction of interleukin 1β expression from human peripheral blood monocyte-derived macrophages by 9-hydroxyoctadecadienoic acid,” Journal of Biological Chemistry, vol. 267, no. 20, pp. 14183–14188, 1992. View at Google Scholar · View at Scopus
  39. T. Mandrup-Poulsen, S. Helqvist, J. Molvig, L. D. Wogensen, and J. Nerup, “Cytokines as immune effector molecules in autoimmune endocrine diseases with special reference to insulin-dependent diabetes mellitus,” Autoimmunity, vol. 4, no. 3, pp. 191–218, 1989. View at Google Scholar · View at Scopus
  40. U. N. Das, “Is obesity an inflammatory condition?” Nutrition, vol. 17, no. 11-12, pp. 953–966, 2001. View at Publisher · View at Google Scholar · View at Scopus
  41. J. M. Fernández-Real and W. Ricart, “Insulin resistance and chronic cardiovascular inflammatory syndrome,” Endocrine Reviews, vol. 24, no. 3, pp. 278–301, 2003. View at Google Scholar · View at Scopus
  42. A. D. Pradhan, J. E. Manson, N. Rifai, J. E. Buring, and P. M. Ridker, “C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus,” Journal of the American Medical Association, vol. 286, no. 3, pp. 327–334, 2001. View at Google Scholar · View at Scopus
  43. W. D. Dudgeon, K. D. Phillips, C. M. Bopp, and G. A. Hand, “Physiological and psychological effects of exercise interventions in HIV disease,” AIDS Patient Care and STDs, vol. 18, no. 2, pp. 81–98, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. B. F. Hurley, R. A. Redmond, R. E. Pratley, M. S. Treuth, M. A. Rogers, and A. P. Goldberg, “Effects of strength training on muscle hypertrophy and muscle cell disruption in elder men,” International Journal of Sports Medicine, vol. 16, no. 6, pp. 378–384, 1995. View at Publisher · View at Google Scholar · View at Scopus
  45. M. L. Kohut, D. A. McCann, D. W. Russell et al., “Aerobic exercise, but not flexibility/resistance exercise, reduces serum IL-18, CRP, and IL-6 independent of β-blockers, BMI, and psychosocial factors in older adults,” Brain, Behavior, and Immunity, vol. 20, no. 3, pp. 201–209, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. M. L. M. P. Jorge, V. N. de Oliveira, N. M. Resende et al., “The effects of aerobic, resistance, and combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin signaling in patients with type 2 diabetes mellitus,” Metabolism: Clinical and Experimental, vol. 60, no. 9, pp. 1244–1252, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. E. S. Ford, “Does exercise reduce inflammation? Physical activity and C-reactive protein among U.S. adults,” Epidemiology, vol. 13, no. 5, pp. 561–568, 2002. View at Google Scholar · View at Scopus
  48. S. Bhasin, T. W. Storer, M. Javanbakht et al., “Testosterone replacement and resistance exercise in HIV-infected men with weight loss and low testosterone levels,” Journal of the American Medical Association, vol. 283, no. 6, pp. 763–770, 2000. View at Google Scholar · View at Scopus
  49. R. Roubenoff, A. McDermott, L. Weiss et al., “Short-term progressive resistance training increases strength and lean body mass in adults infected with human immunodeficiency virus,” AIDS, vol. 13, no. 2, pp. 231–239, 1999. View at Publisher · View at Google Scholar · View at Scopus
  50. R. Roubenoff and I. B. Wilson, “Effect of resistance training on self-reported physical functioning in HIV infection,” Medicine and Science in Sports and Exercise, vol. 33, no. 11, pp. 1811–1817, 2001. View at Google Scholar · View at Scopus
  51. S. Grinspoon, C. Corcoran, K. Parlman et al., “Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting: a randomized, controlled trial,” Annals of Internal Medicine, vol. 133, no. 5, pp. 348–355, 2000. View at Google Scholar · View at Scopus
  52. C. L. Lox, E. McAuley, and R. S. Tucker, “Aerobic and resistance exercise training effects on body composition, muscular strength, and cardiovascular fitness in an HIV-1 population,” International Journal of Behavioral Medicine, vol. 3, no. 1, pp. 55–69, 1996. View at Google Scholar · View at Scopus
  53. L. W. Rigsby, R. K. Dishman, A. W. Jackson, G. S. Maclean, and P. B. Raven, “Effects of exercise training on men seropositive for the human immunodeficiency virus-1,” Medicine and Science in Sports and Exercise, vol. 24, no. 1, pp. 6–12, 1992. View at Google Scholar · View at Scopus
  54. W. D. Dudgeon, K. D. Phillips, J. L. Durstine et al., “Individual exercise sessions alter circulating hormones and cytokines in HIV-infected men,” Applied Physiology, Nutrition and Metabolism, vol. 35, no. 4, pp. 560–568, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. ACSM'S Guidelines for Exercise Testing and Prescription, Lippincott, Williams & Wilkins, Philadelphia, Pa, USA, 2005.
  56. A. Menkes, S. Mazel, R. A. Redmond et al., “Strength training increases regional bone mineral density and bone remodeling in middle-aged and older men,” Journal of Applied Physiology, vol. 74, no. 5, pp. 2478–2484, 1993. View at Google Scholar · View at Scopus
  57. S. Welle, C. Thornton, and M. Statt, “Myofibrillar protein synthesis in young and old human subjects after three months of resistance training,” American Journal of Physiology, vol. 268, no. 3, part 1, pp. E422–E427, 1995. View at Google Scholar · View at Scopus
  58. M. Brzycki, “Strength Testing—predicting a one-rep max from reps to fatigue,” Journal of Physical Education, Recreation, and Dance, vol. 64, no. 1, pp. 88–90, 1993. View at Google Scholar
  59. E. N. Marieb, “Endocrine system,” in Human Anatomy & Physiology, pp. 603–643, Pearson Education, 2006. View at Google Scholar
  60. L. R. Keytel, J. H. Goedecke, T. D. Noakes et al., “Prediction of energy expenditure from heart rate monitoring during submaximal exercise,” Journal of Sports Sciences, vol. 23, no. 3, pp. 289–297, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. W. D. Dudgeon, K. D. Phillips, J. L. Durstine et al., “Individual exercise sessions alter circulating hormones and cytokines in HIV-infected men,” Applied Physiology, Nutrition and Metabolism, vol. 35, no. 4, pp. 560–568, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. W. D. Dudgeon, K. D. Phillips, J. A. Carson, R. B. Brewer, J. L. Durstine, and G. A. Hand, “Counteracting muscle wasting in HIV-infected individuals,” HIV Medicine, vol. 7, no. 5, pp. 299–310, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. G. A. Hand, K. D. Phillips, W. D. Dudgeon, G. W. Lyerly, J. L. Durstine, and S. E. Burgess, “Moderate intensity exercise training reverses functional aerobic impairment in HIV-infected individuals,” AIDS Care, vol. 20, no. 9, pp. 1066–1074, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. D. Agin, D. Gallagher, J. Wang, S. B. Heymsfield, R. N. Pierson, and D. P. Kotler, “Effects of whey protein and resistance exercise on body cell mass, muscle strength, and quality of life in women with HIV,” AIDS, vol. 15, no. 18, pp. 2431–2440, 2001. View at Publisher · View at Google Scholar · View at Scopus
  65. D. W. Spence, M. L. A. Galantino, K. A. Mossberg, and S. O. Zimmerman, “Progressive resistance exercise: effect on muscle function and anthropometry of a select AIDS population,” Archives of Physical Medicine and Rehabilitation, vol. 71, no. 9, pp. 644–648, 1990. View at Google Scholar · View at Scopus
  66. T. Hortobágyi, N. J. Lambert, and J. P. Hill, “Greater cross education following training with muscle lengthening than shortening,” Medicine and Science in Sports and Exercise, vol. 29, no. 1, pp. 107–112, 1997. View at Publisher · View at Google Scholar · View at Scopus
  67. D. A. Cooper, “Life and death in the cART era,” The Lancet, vol. 372, no. 9635, pp. 266–267, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. R. R. Kraemer, J. L. Kilgore, G. R. Kraemer, and V. D. Castracane, “Growth hormone, IGF-I, and testosterone responses to resistive exercise,” Medicine and Science in Sports and Exercise, vol. 24, no. 12, pp. 1346–1352, 1992. View at Google Scholar · View at Scopus
  69. W. J. Kraemer, K. Häkkinen, R. U. Newton et al., “Effects of heavy-resistance training on hormonal response patterns in younger versus older men,” Journal of Applied Physiology, vol. 87, no. 3, pp. 982–992, 1999. View at Google Scholar · View at Scopus
  70. L. R. Watkins, S. F. Maier, and L. E. Goehler, “Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states,” Pain, vol. 63, no. 3, pp. 289–302, 1995. View at Publisher · View at Google Scholar · View at Scopus
  71. M. A. Febbraio and B. K. Pedersen, “Muscle-derived interleukin-6: mechanisms for activation and possible biological roles,” FASEB Journal, vol. 16, no. 11, pp. 1335–1347, 2002. View at Publisher · View at Google Scholar · View at Scopus
  72. A. M. W. Petersen and B. K. Pedersen, “The anti-inflammatory effect of exercise,” Journal of Applied Physiology, vol. 98, no. 4, pp. 1154–1162, 2005. View at Publisher · View at Google Scholar · View at Scopus
  73. J. L. Abramson and V. Vaccarino, “Relationship between physical activity and inflammation among apparently healthy middle-aged and older US adults,” Archives of Internal Medicine, vol. 162, no. 11, pp. 1286–1292, 2002. View at Google Scholar · View at Scopus
  74. K. E. Fallon, S. K. Fallon, and T. Boston, “The acute phase response and exercise: court and field sports,” British Journal of Sports Medicine, vol. 35, no. 3, pp. 170–173, 2001. View at Publisher · View at Google Scholar · View at Scopus
  75. D. F. Geffken, M. Cushman, G. L. Burke, J. F. Polak, P. A. Sakkinen, and R. P. Tracy, “Association between physical activity and markers of inflammation in a healthy elderly population,” American Journal of Epidemiology, vol. 153, no. 3, pp. 242–250, 2001. View at Publisher · View at Google Scholar · View at Scopus
  76. D. E. King, P. Carek, A. G. Mainous, and W. S. Pearson, “Inflammatory markers and exercise: differences related to exercise type,” Medicine and Science in Sports and Exercise, vol. 35, no. 4, pp. 575–581, 2003. View at Publisher · View at Google Scholar · View at Scopus
  77. A. M. W. Petersen and B. K. Pedersen, “The anti-inflammatory effect of exercise,” Journal of Applied Physiology, vol. 98, no. 4, pp. 1154–1162, 2005. View at Publisher · View at Google Scholar · View at Scopus
  78. L. M. Winer, M. A. Shaw, and G. Baumann, “Urinary growth hormone excretion rates in normal and acromegalic man: a critical appraisal of its potential clinical utility,” Journal of Endocrinological Investigation, vol. 12, no. 7, pp. 461–467, 1989. View at Google Scholar · View at Scopus
  79. K. Häkkinen, A. Pakarinen, W. J. Kraemer, R. U. Newton, and M. Alen, “Basal concentrations and acute responses of serum hormones and strength development during heavy resistance training in middle-aged and elderly men and women,” Journals of Gerontology. Series A, vol. 55, no. 2, pp. B95–B105, 2000. View at Google Scholar · View at Scopus
  80. J. O. Marx, N. A. Ratamess, B. C. Nindl et al., “Low-volume circuit versus high-volume periodized resistance training in women,” Medicine and Science in Sports and Exercise, vol. 33, no. 4, pp. 635–643, 2001. View at Google Scholar · View at Scopus
  81. E. T. Poehlman, C. J. Rosen, and K. C. Copeland, “The influence of endurance training on insulin-like growth factor-1 in older individuals,” Metabolism: Clinical and Experimental, vol. 43, no. 11, pp. 1401–1405, 1994. View at Publisher · View at Google Scholar · View at Scopus
  82. B. C. Nindl, S. A. Headley, A. P. Tuckow et al., “IGF-I system responses during 12 weeks of resistance training in end-stage renal disease patients,” Growth Hormone and IGF Research, vol. 14, no. 3, pp. 245–250, 2004. View at Publisher · View at Google Scholar · View at Scopus
  83. L. Di Luigi, L. Guidetti, M. Nordio, C. Baldari, and F. Romanelli, “Acute effect of physical exercise on serum insulin-like growth factor-binding protein 2 and 3 in healthy men: role of exercise-linked growth hormone secretion,” International Journal of Sports Medicine, vol. 22, no. 2, pp. 103–110, 2001. View at Publisher · View at Google Scholar · View at Scopus
  84. J. P. Ahtiainen, A. Pakarinen, M. Alen, W. J. Kraemer, and K. Häkkinen, “Short vs. long rest period between the sets in hypertrophic resistance training: influence on muscle strength, size, and hormonal adaptations in trained men,” Journal of Strength and Conditioning Research, vol. 19, no. 3, pp. 572–582, 2005. View at Publisher · View at Google Scholar · View at Scopus
  85. I. Smilios, T. Pilianidis, M. Karamouzis, and S. P. Tokmakidis, “Hormonal responses after various resistance exercise protocols,” Medicine and Science in Sports and Exercise, vol. 35, no. 4, pp. 644–654, 2003. View at Publisher · View at Google Scholar · View at Scopus
  86. N. Amirayan-Chevillard, H. Tissot-Dupont, Y. Obadia, H. Gallais, J. L. Mege, and C. Capo, “Highly active antiretroviral therapy (HAART) and circulating markers of immune activation: specific effect of HAART on Neopterin,” Clinical and Diagnostic Laboratory Immunology, vol. 7, no. 5, pp. 832–834, 2000. View at Publisher · View at Google Scholar · View at Scopus